Advertisement
Screener

SAFECODE DRUG TECHNOLOGIES CORP. Interest Expense

Add as a preferred source on Google

SAFECODE DRUG TECHNOLOGIES CORP. Interest Expense

SAFECODE DRUG TECHNOLOGIES CORP. reported Interest Expense of $40.83 thousand for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-13.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2013-08-13

  • SAFECODE DRUG TECHNOLOGIES CORP. interest expense for the quarter ending 2013-06-30 was $40.83K.
  • SAFECODE DRUG TECHNOLOGIES CORP. interest expense for the quarter ending 2013-03-31 was $34.22K.
  • SAFECODE DRUG TECHNOLOGIES CORP. interest expense for the quarter ending 2012-03-31 was $0.00.
  • SAFECODE DRUG TECHNOLOGIES CORP. interest expense for fiscal 2012 was $7.19K.
  • SAFECODE DRUG TECHNOLOGIES CORP. interest expense for fiscal 2011 was $0.00.
Period endInterest Expense 3 monthInterest Expense 6 monthInterest Expense 12 monthInterest Expense 25 monthInterest Expense 28 monthInterest Expense 31 month
2013-06-30$40.83K
10-Q · filed 2013-08-13		$75.05K
10-Q · filed 2013-08-13		$82.24K
10-Q · filed 2013-08-13
2013-03-31$34.22K
10-Q · filed 2013-05-10		$41.41K
10-Q · filed 2013-05-10
2012-12-31$7.19K
10-K · filed 2013-03-25		$7.19K
10-K · filed 2013-03-25
2012-03-31$0.00
10-Q · filed 2013-05-10
2011-12-31$0.00
10-K · filed 2013-03-25
Advertisement